Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 45

1.

Limitations of Available Studies Prevent Reliable Comparison Between Tumour Ablation and Partial Nephrectomy for Patients with Localised Renal Masses: A Systematic Review from the European Association of Urology Renal Cell Cancer Guideline Panel.

Abu-Ghanem Y, Fernández-Pello S, Bex A, Ljungberg B, Albiges L, Dabestani S, Giles RH, Hofmann F, Hora M, Kuczyk MA, Kuusk T, Marconi L, Merseburger AS, Tahbaz R, Staehler M, Volpe A, Powles T, Lam TB, Bensalah K.

Eur Urol Oncol. 2020 Mar 31. pii: S2588-9311(20)30026-2. doi: 10.1016/j.euo.2020.02.001. [Epub ahead of print]

PMID:
32245655
2.

[A COMPARISON BETWEEN TWO POTASSIUM CITRATE REGIMENS FOR THE TREATMENT OF NEPHROLITHIASIS].

Drori T, Abu-Ghanem Y, Kleinmann N, Shvero A, Winkler HZ, Zilberman DE.

Harefuah. 2019 Dec;158(12):774-777. Hebrew.

PMID:
31823528
3.

Impact of perioperative blood transfusions on clinical outcomes in patients undergoing surgery for major urologic malignancies.

Abu-Ghanem Y, Ramon J.

Ther Adv Urol. 2019 Aug 12;11:1756287219868054. doi: 10.1177/1756287219868054. eCollection 2019 Jan-Dec. Review.

4.

Management of Sporadic Renal Angiomyolipomas: A Systematic Review of Available Evidence to Guide Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel.

Fernández-Pello S, Hora M, Kuusk T, Tahbaz R, Dabestani S, Abu-Ghanem Y, Albiges L, Giles RH, Hofmann F, Kuczyk MA, Lam TB, Marconi L, Merseburger AS, Powles T, Staehler M, Volpe A, Ljungberg B, Bex A, Bensalah K.

Eur Urol Oncol. 2020 Feb;3(1):57-72. doi: 10.1016/j.euo.2019.04.005. Epub 2019 Jun 4. Review.

PMID:
31171501
5.

Prediction of Surgical Intervention for Distal Ureteral Stones.

Modai J, Avda Y, Shpunt I, Abu-Ghanem Y, Leibovici D, Shilo Y.

J Endourol. 2019 Sep;33(9):750-754. doi: 10.1089/end.2019.0187. Epub 2019 Jun 27.

PMID:
31154851
6.

Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma.

Albiges L, Powles T, Staehler M, Bensalah K, Giles RH, Hora M, Kuczyk MA, Lam TB, Ljungberg B, Marconi L, Merseburger AS, Volpe A, Abu-Ghanem Y, Dabestani S, Fernández-Pello S, Hofmann F, Kuusk T, Tahbaz R, Bex A.

Eur Urol. 2019 Aug;76(2):151-156. doi: 10.1016/j.eururo.2019.05.022.

PMID:
31151678
7.

Editorial on "Risk prediction models for cancer-specific survival following cytoreductive nephrectomy in the contemporary era".

Abu-Ghanem Y, Ramon J.

Ann Transl Med. 2019 Mar;7(Suppl 1):S36. doi: 10.21037/atm.2019.02.25. No abstract available.

8.

Seroprevalence of hepatitis E virus in dromedary camels, Bedouins, Muslim Arabs and Jews in Israel, 2009-2017.

Bassal R, Wax M, Shirazi R, Shohat T, Cohen D, David D, Abu-Mouch S, Abu-Ghanem Y, Mendelson E, Ben-Ari Z, Mor O.

Epidemiol Infect. 2019 Jan;147:e92. doi: 10.1017/S0950268819000062.

9.

European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update.

Ljungberg B, Albiges L, Abu-Ghanem Y, Bensalah K, Dabestani S, Fernández-Pello S, Giles RH, Hofmann F, Hora M, Kuczyk MA, Kuusk T, Lam TB, Marconi L, Merseburger AS, Powles T, Staehler M, Tahbaz R, Volpe A, Bex A.

Eur Urol. 2019 May;75(5):799-810. doi: 10.1016/j.eururo.2019.02.011. Epub 2019 Feb 23.

PMID:
30803729
10.

Intraoperative but not postoperative blood transfusion adversely affect cancer recurrence and survival following nephrectomy for renal cell carcinoma.

Abu-Ghanem Y, Dotan Z, Zilberman DE, Kaver I, Ramon J.

Sci Rep. 2019 Feb 4;9(1):1160. doi: 10.1038/s41598-018-37691-4.

11.

Multiple Injuries to the Lower Urinary Tract: Two Cases and Comparison with the EAU Guidelines.

Lumen N, Sharma D, Abu-Ghanem Y, Djakovic N, Kuehhas F, Serafetinidis E, Sujenthiran A, Waterloos M, Hallscheidt P, Kitrey ND.

Case Rep Urol. 2018 Dec 18;2018:3216527. doi: 10.1155/2018/3216527. eCollection 2018.

12.

A Joint Statement from the European Association of Urology Renal Cell Cancer Guidelines Panel and the International Kidney Cancer Coalition: The Rejection of Ipilimumab and Nivolumab for Renal Cancer by the Committee for Medicinal Products for Human Use Does not Change Evidence-based Guideline Recommendations.

Bex A, Albiges L, Staehler M, Bensalah K, Giles RH, Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam TB, Marconi L, Merseburger AS, Fernández-Pello S, Tahbaz R, Abu-Ghanem Y, Volpe A, Ljungberg B, Escudier B, Powles T.

Eur Urol. 2018 Dec;74(6):849-851. doi: 10.1016/j.eururo.2018.08.029. Epub 2018 Sep 7. No abstract available.

PMID:
30201510
13.

Updated European Association of Urology Guidelines for Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Clear-cell Renal Cell Carcinoma.

Bex A, Albiges L, Ljungberg B, Bensalah K, Dabestani S, Giles RH, Hofmann F, Hora M, Kuczyk MA, Lam TB, Marconi L, Merseburger AS, Fernández-Pello S, Tahbaz R, Abu-Ghanem Y, Staehler M, Volpe A, Powles T.

Eur Urol. 2018 Dec;74(6):805-809. doi: 10.1016/j.eururo.2018.08.008. Epub 2018 Aug 31.

PMID:
30177291
14.

24-h urine metabolic profile: is it necessary in all kidney stone formers?

Abu-Ghanem Y, Shvero A, Kleinmann N, Winkler HZ, Zilberman DE.

Int Urol Nephrol. 2018 Jul;50(7):1243-1247. doi: 10.1007/s11255-018-1902-1. Epub 2018 Jun 6.

PMID:
29876775
15.

Low Intensity Shock Wave Treatment for Erectile Dysfunction-How Long Does the Effect Last?

Kitrey ND, Vardi Y, Appel B, Shechter A, Massarwi O, Abu-Ghanem Y, Gruenwald I.

J Urol. 2018 Jul;200(1):167-170. doi: 10.1016/j.juro.2018.02.070. Epub 2018 Mar 1.

PMID:
29477719
16.

Secular trends in the appropriateness of empirical antibiotic treatment in patients with bacteremia: a comparison between three prospective cohorts.

Daitch V, Akayzen Y, Abu-Ghanem Y, Eliakim-Raz N, Paul M, Leibovici L, Yahav D.

Eur J Clin Microbiol Infect Dis. 2018 Mar;37(3):455-462. doi: 10.1007/s10096-018-3190-1. Epub 2018 Jan 20.

PMID:
29353378
17.

Retzius space reconstruction following transperitoneal laparoscopic robot-assisted radical prostatectomy: does it have any added value?

Abu-Ghanem Y, Dotan Z, Ramon J, Zilberman DE.

J Robot Surg. 2018 Sep;12(3):475-479. doi: 10.1007/s11701-017-0768-z. Epub 2017 Nov 27.

PMID:
29181778
18.

Oncologic Outcomes of Partial Nephrectomy for Stage T3a Renal Cell Cancer.

Shvero A, Nativ O, Abu-Ghanem Y, Zilberman D, Zaher B, Levitt M, Fridman E, Portnoy O, Ramon J, Dotan ZA.

Clin Genitourin Cancer. 2018 Jun;16(3):e613-e617. doi: 10.1016/j.clgc.2017.10.016. Epub 2017 Nov 7.

PMID:
29174471
19.

Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.

Abu-Ghanem Y, Ramon J, Berger R, Kaver I, Fridman E, Leibowitz-Amit R, Dotan ZA.

World J Surg Oncol. 2017 Nov 2;15(1):193. doi: 10.1186/s12957-017-1257-6.

20.

Perioperative blood transfusion adversely affects prognosis after nephrectomy for renal cell carcinoma.

Abu-Ghanem Y, Zilberman DE, Dotan Z, Kaver I, Ramon J.

Urol Oncol. 2018 Jan;36(1):12.e15-12.e20. doi: 10.1016/j.urolonc.2017.09.006. Epub 2017 Oct 6.

PMID:
28993059

Supplemental Content

Loading ...
Support Center